CJC-1295/ IPAMORELIN BLEND 20mg

CJC-1295/ IPAMORELIN BLEND 20mg

$90.00
Skip to product information
CJC-1295/ IPAMORELIN BLEND 20mg
  • CJC-1295/ IPAMORELIN BLEND 20mg
  • CJC-1295/ IPAMORELIN BLEND 20mg
CJC-1295/ IPAMORELIN BLEND 20mg

CJC-1295/ IPAMORELIN BLEND 20mg

$90.00
Shipping calculated at checkout.

Growth Hormone Signaling & Pituitary Research

What Is CJC-1295 / Ipamorelin?

CJC-1295 / Ipamorelin is a two-peptide research blend combining compounds associated with different pathways involved in growth hormone release.

CJC-1295 is associated with the growth hormone-releasing hormone pathway. Ipamorelin is a growth hormone secretagogue—a compound studied for its ability to trigger growth hormone release through a separate signaling pathway.

Together, these components offer a subject for investigating how different signals influence the pituitary gland, which produces and releases growth hormone.

Why Are Researchers Interested?

Growth hormone is released in pulses rather than at a constant rate. Researchers examine how signaling compounds affect the size, timing, and duration of those pulses, along with downstream changes in insulin-like growth factor 1, or IGF-1.

The two components are relevant to research into the regulation of this system. Studying their individual activity and their activity in combination can help distinguish the contribution of each signaling pathway.

Key Areas of Research

Growth hormone secretion: Measuring changes in hormone release and the duration of the response.
Pituitary signaling: Exploring how different receptor pathways influence hormone-producing cells.
Hormone pulse patterns: Investigating the timing and structure of growth hormone secretion.
IGF-1 signaling: Examining downstream responses associated with the growth hormone system.

Research Context

The exact CJC component matters. CJC-1295 with DAC and products commonly labeled “CJC-1295 without DAC” differ in their formulation and duration of activity. Research on long-acting CJC-1295 should not be treated as interchangeable with research on a no-DAC formulation.

Studies of either component individually do not establish the effects of the finished blend. The product’s stated identity and component ratio should guide its interpretation in research.

Research Use Disclaimer

For laboratory and scientific research use only. Not intended for human or veterinary use, consumption, or administration. Not intended to diagnose, treat, cure, mitigate, or prevent any disease. Information on this page is provided for educational and research reference purposes and is not medical advice. Ethos Bioscience does not make medical claims regarding this product.
🧬 Mechanism

📖

Education

💉

Reconstitution
Details

Research Use Only

Ethos Bioscience compounds are supplied exclusively for lawful laboratory and scientific research. Product specifications, concentration, and labeling are provided on each individual product page.


Storage & Handling

Store according to the handling guidance provided with the product and protect from unnecessary heat, light, and moisture. Follow appropriate laboratory handling procedures at all times.


Important Notice

Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease or medical condition.
Shipping & Returns

Every Ethos Bioscience order is prepared with attention to accuracy, packaging integrity, and timely fulfillment. Orders are typically processed within 1–2 business days, with tracking provided once shipment is underway.


To protect product integrity, return requests are reviewed on a case-by-case basis. If your shipment arrives damaged, incorrect, or incomplete, please contact our team promptly so we can assess the issue and provide the appropriate resolution.

RESEARCH PROFILE / CJC-1295/ IPAMORELIN BLEND 20mg

THE SCIENCE, WITHOUT THE SCAVENGER HUNT.

Mechanism, evidence, limitations, and documentation - organized in one place.

RESEARCH CATEGORYResearch pathway profile
PRIMARY PATHWAYSCompound-specific signaling
MOLECULAR TYPEResearch material
RESEARCH STATUSInvestigational

01 / ORIENTATION

WHAT IS IT?

Growth Hormone Signaling & Pituitary Research

What Is CJC-1295 / Ipamorelin?

CJC-1295 / Ipamorelin is a two-peptide research blend combining compounds associated with different pathways involved in growth hormone release.

CJC-1295 is associated with the growth hormone-releasing hormone pathway. Ipamorelin is a growth hormone secretagogue—a compound studied for its ability to trigger growth hormone release through a separate signaling pathway.

Together, these components offer a subject for investigating how different signals influence the pituitary gland, which produces and releases growth hormone.

Why Are Researchers Interested?

Growth hormone is released in pulses rather than at a constant rate. Researchers examine how signaling compounds affect the size, timing, and duration of those pulses, along with downstream changes in insulin-like growth factor 1, or IGF-1.

The two components are relevant to research into the regulation of this system. Studying their individual activity and their activity in combination can help distinguish the contribution of each signaling pathway.

Key Areas of Research

Growth hormone secretion: Measuring changes in hormone release and the duration of the response.
Pituitary signaling: Exploring how different receptor pathways influence hormone-producing cells.
Hormone pulse patterns: Investigating the timing and structure of growth hormone secretion.
IGF-1 signaling: Examining downstream responses associated with the growth hormone system.

Research Context

The exact CJC component matters. CJC-1295 with DAC and products commonly labeled “CJC-1295 without DAC” differ in their formulation and duration of activity. Research on long-acting CJC-1295 should not be treated as interchangeable with research on a no-DAC formulation.

Studies of either component individually do not establish the effects of the finished blend. The product’s stated identity and component ratio should guide its interpretation in research.

Research Use Disclaimer

For laboratory and scientific research use only. Not intended for human or veterinary use, consumption, or administration. Not intended to diagnose, treat, cure, mitigate, or prevent any disease. Information on this page is provided for educational and research reference purposes and is not medical advice. Ethos Bioscience does not make medical claims regarding this product.

02 / RESEARCH INTEREST

WHY RESEARCHERS ARE LOOKING

  • How compound-specific signaling is studied in controlled laboratory models
  • Which downstream cellular signals and measurable endpoints change
  • How dose, duration, model selection, and study design affect results
  • Where preclinical findings do—and do not—translate to human research

03 / MECHANISM

THE PATHWAY IS THE POINT.

This profile centers on compound-specific signaling. Researchers evaluate how activity within these pathways changes downstream signaling, biomarkers, and experimental endpoints. Results depend on the specific molecule, model, dose, duration, and study design.

04 / EVIDENCE AT A GLANCE

THE EVIDENCE, PROPERLY LABELED

RESEARCH CONTEXT

WHAT THE RESEARCH SHOWS

Published evidence for materials in this research category varies by molecule and may include mechanistic, in-vitro, animal, or human research. Product-specific conclusions require review of the named compound, study design, population, dose, duration, and measured endpoints.

WHAT IT DOES NOT ESTABLISH

Scientific literature does not independently establish the identity, purity, safety, or suitability of this supplied material. Mechanistic or preclinical findings should not be treated as proof of human outcomes, medical benefit, or product-specific quality.

05 / PUBLISHED RESEARCH

READ THE ACTUAL WORK.

Last reviewed: September 2026

Compound-specific references are being reviewed and will be added here as the research profile is expanded.

These publications concern named investigational molecules and pathway research. They provide scientific context; they do not independently validate this product or constitute medical guidance.

06 / QUALITY DOCUMENTATION

THE PAPER TRAIL BELONGS ON THE PAGE.

Product-specific documentation should be evaluated separately from published research.

BATCH
Available on product documentation
TEST DATE
See current report
DOCUMENT
Manufacturer Provided COA
COA LINK PENDING
RESEARCH USE NOTICE

For lawful laboratory and scientific research only. Not for human or veterinary use. Information is educational and is not medical advice.

Featured Collection

ETH - GI1 30MG

ETH - GI1 30MG

$150.00
MAP THE METABOLIC PATHWAY →
KLOW 80mg

KLOW 80mg

$110.00
MAP THE RECOVERY STACK →
NAD+ 500mg

NAD+ 500mg

$60.00
RECHARGE THE RESEARCH →
TESAMORELIN 10mg

TESAMORELIN 10mg

$70.00
TURN UP THE SIGNAL →
TB4 10mg

TB4 10mg

$65.00
TRACK TISSUE DYNAMICS →
AHK-CU 100mg

AHK-CU 100mg

$55.00
MAP THE METABOLIC PATHWAY →
BEAUTY BLEND 70mg

BEAUTY BLEND 70mg

$75.00
EXPLORE THE BEAUTY SIGNAL →
View all →